Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1988 Apr;34:895–898.

Non-Invasive Prenatal Testing

Barbara C McGillivray
PMCID: PMC2218979  PMID: 21253096

Abstract

Non-invasive modalities to assess the ongoing pregnancy may assist the clinician to identify risk factors requiring additions or alteration to routine prenatal care. These modalities include pedigree analysis, maternal serum alphafetoprotein screening, fetal ultrasonography, and Doppler ultrasound. These methods should be used when there are appropriate clinical indications and awareness of their limitations.

Keywords: maternal serum alphafetoprotein screening, ultrasound, fetal echocardiography, Doppler ultrasound

Full text

PDF
895

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Doran T. A., Valentine G. H., Wong P. Y., Wielgosz G., Benzie R. J., Soltan H. C., Jenner M. R., Morland P. A., Montgomery R. J., Allen L. C. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project. CMAJ. 1987 Aug 15;137(4):285–293. [PMC free article] [PubMed] [Google Scholar]
  2. Drogari E., Smith I., Beasley M., Lloyd J. K. Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHSS Phenylketonuria Register. Lancet. 1987 Oct 24;2(8565):927–930. doi: 10.1016/s0140-6736(87)91418-8. [DOI] [PubMed] [Google Scholar]
  3. Goldman J. A., Dicker D., Feldberg D., Yeshaya A., Samuel N., Karp M. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Am J Obstet Gynecol. 1986 Aug;155(2):293–297. doi: 10.1016/0002-9378(86)90812-4. [DOI] [PubMed] [Google Scholar]
  4. Hayslett J. P., Reece E. A. Systemic lupus erythematosus in pregnancy. Clin Perinatol. 1985 Oct;12(3):539–550. [PubMed] [Google Scholar]
  5. Lippman A., Evans J. A. Screening for maternal serum alpha-fetoprotein: what about the low side? CMAJ. 1987 Apr 15;136(8):801–804. [PMC free article] [PubMed] [Google Scholar]
  6. Merkatz I. R., Nitowsky H. M., Macri J. N., Johnson W. E. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984 Apr 1;148(7):886–894. doi: 10.1016/0002-9378(84)90530-1. [DOI] [PubMed] [Google Scholar]
  7. Trudinger B. J., Cook C. M., Giles W. B., Connelly A., Thompson R. S. Umbilical artery flow velocity waveforms in high-risk pregnancy. Randomised controlled trial. Lancet. 1987 Jan 24;1(8526):188–190. doi: 10.1016/s0140-6736(87)90003-1. [DOI] [PubMed] [Google Scholar]
  8. Trudinger B. J. The umbilical circulation. Semin Perinatol. 1987 Oct;11(4):311–321. [PubMed] [Google Scholar]
  9. Wald N. J., Cuckle H., Brock J. H., Peto R., Polani P. E., Woodford F. P. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet. 1977 Jun 25;1(8026):1323–1332. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES